Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Myasthenia gravis, Castleman disease, pemphigus, and anti-phospholipid syndrome.

Jakubíková M, Piťha J, Latta J, Ehler E, Schutzner J.

Muscle Nerve. 2013 Mar;47(3):447-51. doi: 10.1002/mus.23657. Epub 2013 Feb 6.

PMID:
23386221
2.

Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.

Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt GJ, Jablonska S.

J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):393-400. Review.

PMID:
10459112
3.

[Castleman tumor, lichen ruber and pemphigus vulgaris: paraneoplastic association of immunological diseases?].

Plewig G, Jansen T, Jungblut RM, Röher HD.

Hautarzt. 1990 Dec;41(12):662-70. Review. German.

PMID:
2089024
4.

Coexistence of myasthenia gravis and pemphigus foliaceus.

Kim HT, Kim SH, Kim JH, Kim MH, Lee CW.

J Korean Med Sci. 1995 Aug;10(4):298-302.

5.

Castleman's disease associated with myasthenia gravis.

Day JR, Bew D, Ali M, Dina R, Smith PL.

Ann Thorac Surg. 2003 May;75(5):1648-50.

PMID:
12735602
6.

Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.

Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E.

J Neurol Sci. 2011 Mar 15;302(1-2):112-3. doi: 10.1016/j.jns.2010.12.013. Epub 2011 Jan 13.

PMID:
21236448
7.

Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.

Wang J, Zhu X, Li R, Tu P, Wang R, Zhang L, Li T, Chen X, Wang A, Yang S, Wu Y, Yang H, Ji S.

Arch Dermatol. 2005 Oct;141(10):1285-93. Review.

PMID:
16230567
8.

Myasthenia gravis with giant lymph node hyperplasia: report of a case.

Lee CC, Ko PT, Huang CC.

J Formos Med Assoc. 1993 Apr;92(4):382-4.

PMID:
8104589
9.

[A case of myasthenia gravis associated with systemic lupus erythematosus and pemphigus erythematosus].

Itoh K, Umehara F, Iwasaki H, Kanda A, Arimura K.

Rinsho Shinkeigaku. 1997 Feb;37(2):111-4. Japanese.

PMID:
9164141
10.

On the frontline: what an optometrist needs to know about myasthenia gravis.

Pruitt JA, Ilsen PF.

Optometry. 2010 Sep;81(9):454-60. doi: 10.1016/j.optm.2009.09.023. Epub 2010 Jul 22.

PMID:
20655284
11.

Juvenile myasthenia gravis: three case reports and a literature review.

Gadient P, Bolton J, Puri V.

J Child Neurol. 2009 May;24(5):584-90. doi: 10.1177/0883073808325651. Review.

PMID:
19406758
12.

An unusual presentation of myasthenia gravis.

Chijoke A, Ogunmodele JA.

West Afr J Med. 2009 Nov-Dec;28(6):391-3.

PMID:
20486100
13.

[Coexistence of pemphigus erythematosus and myasthenia gravis].

Jablonska S, Chorzelski T, Lebioda J.

Hautarzt. 1970 Apr;21(4):156-60. German. No abstract available.

PMID:
4945047
14.

Rituximab in severe seronegative juvenile myasthenia gravis: review of the literature.

Koul R, Al Futaisi A, Abdwani R.

Pediatr Neurol. 2012 Sep;47(3):209-12. doi: 10.1016/j.pediatrneurol.2012.05.017.

PMID:
22883288
15.

Paraneoplastic syndrome and intrathoracic Castleman disease.

Hung IJ, Lin JJ, Yang CP, Hsueh C.

Pediatr Blood Cancer. 2006 Oct 15;47(5):616-20.

PMID:
16047366
16.

Lymphoid hyperplasia of the thymus showing Castleman's disease in a patient with myasthenia gravis.

Kojima M, Shimizu K, Kaneko Y, Masawa N, Nakamura N.

Rheumatol Int. 2012 Nov;32(11):3695-7. doi: 10.1007/s00296-011-2161-y. Epub 2011 Sep 27. No abstract available.

PMID:
21947379
17.

Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature.

Menenakos C, Braumann C, Hartmann J, Jacobi CA.

World J Surg Oncol. 2007 Apr 28;5:45. Review.

18.

Retroperitoneal Castlemans disease associated with paraneoplastic pemphigus.

Choh NA, Qayoom S, Shaheen F, Malik RA, Rabbani I, Gojwari T.

Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):93-6. doi: 10.1016/j.hemonc.2013.11.002. Epub 2013 Dec 12.

19.

Coexistence of peculiar pemphigus, myasthenia gravis and malignant thymoma.

Tagami H, Imamura S, Noguchi S, Nishitani H.

Dermatologica. 1976;152(3):181-90.

PMID:
939344
20.

Supplemental Content

Support Center